Showing 761-770 of 2349 results for "".
Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Don't Wait: Rethinking Parkinson's Disease Care for Brain Health
https://practicalneurology.com/diseases-diagnoses/movement-disorders/dont-wait-rethinking-parkinsons-disease-care-for-brain-health/36533/A holistic, brain-health-first approach and access to innovative treatments can give patients more than hope. It can give them back their time.Neuromuscular Notes: New and Emerging Therapies in ALS
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-new-and-emerging-therapies-in-als/32007/New therapies—including antisense oligonucleotides, mesenchymal stem cells, and kinase inhibitors—are in development to target specific pathogenic mechanisms identified in ALS.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Dystrophinopathies and the Limb-Girdle Muscular Dystrophies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/dystrophinopathies-and-the-limb-girdle-muscular-dystrophies/32028/Disease management for dystrophinopathies and limb-girdle muscular dystrophies has evolved from palliation to genetic therapeutics, paving the way toward a cure.Neural Antibodies as Diagnostic Biomarkers of Autoimmune Encephalitis and Inflammatory Demyelinating Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neural-antibodies-as-diagnostic-biomarkers-of-autoimmune-encephalitis-and-inflammatory-demyelinating-disease/32103/Neural antibodies are diagnostic biomarkers of autoimmune encephalitis, NMOSD, and MOGAD.Challenge Case Report: New-Onset Seizures and Brain Lesions in First Trimester
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/challenging-case-report-new-onset-seizures-and-brain-lesions-in-first-trimester/31734/A woman age 29 and 10 weeks pregnant presented with new-onset seizures and imaging demonstrated previously undiagnosed lesions.Atrial Cardiopathy and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/atrial-cardiopathy-and-stroke/31614/The past decade there has been a resurgence in understanding of the relationship of atrial fibrillation to stroke.Case Report: Hyperekplexia & Encephalopathy
https://practicalneurology.com/diseases-diagnoses/child-neurology/case-report-hyperekplexia-encephalopathy/31867/A novel glycine receptor Β (GLRB) variant was identified in 2 unrelated children of Puerto Rican descent who both had hyperekplexia and encephalopathy.- When the Problem is the Patient: How to Handle Bothersome Behaviorhttps://practicalneurology.com/columns/practice-management/when-the-problem-is-the-patient-how-to-handle-bothersome-behavior/31231/In the January 2007 issue of Practical Neurology, Dr. Randolph W. Evans highlights a significant yet under-discussed issue within the medical community: bothersome patient behaviors as reported by neurologists. Motivated by a 2005 New York Times article where patients criticized physicians for being